HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.

Abstract
The promyelocytic leukemia (PML) protein is a tumor suppressor originally identified in acute promyelocytic leukemia and implicated in tumorigenesis in multiple forms of cancer. Here, we demonstrate that the PML protein undergoes ubiquitination-mediated degradation facilitated by an E3 ligase UHRF1 (ubiquitin-like with PHD and RING finger domains 1), which is commonly upregulated in various human malignancies. Furthermore, UHRF1 negatively regulates PML protein accumulation in primary human umbilical vein endothelial cells (HUVECs), HEK 293 cells and cancer cells. Knockdown of UHRF1 upregulates whereas ectopic overexpression of UHRF1 downregulates protein abundance of endogenous or exogenous PML, doing so through its binding to the N-terminus of PML. Overexpression of wild-type UHRF1 shortens PML protein half-life and promotes PML polyubiquitination, whereas deletion of the RING domain or coexpression of the dominant-negative E2 ubiquitin-conjugating enzyme, E2D2, attenuates this modification to PML. Finally, knockdown of UHRF1 prolongs PML half-life and increases PML protein accumulation, yet inhibits cell migration and in vitro capillary tube formation, whereas co-knockdown of PML compromises this inhibitory effect. These findings suggest that UHRF1 promotes the turnover of PML protein, and thus targeting UHRF1 to restore PML-mediated tumor suppression represents a promising, novel, anticancer strategy.
AuthorsD Guan, D Factor, Yu Liu, Z Wang, H-Y Kao
JournalOncogene (Oncogene) Vol. 32 Issue 33 Pg. 3819-28 (Aug 15 2013) ISSN: 1476-5594 [Electronic] England
PMID22945642 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • CCAAT-Enhancer-Binding Proteins
  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • RNA, Small Interfering
  • Transcription Factors
  • Tumor Suppressor Proteins
  • PML protein, human
  • UHRF1 protein, human
  • Ubiquitin-Protein Ligases
Topics
  • Blotting, Western
  • CCAAT-Enhancer-Binding Proteins (metabolism)
  • Endothelial Cells (metabolism)
  • Epigenesis, Genetic
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Immunoprecipitation
  • Microscopy, Fluorescence
  • Neoplasms (metabolism)
  • Nuclear Proteins (metabolism)
  • Promyelocytic Leukemia Protein
  • RNA, Small Interfering
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors (metabolism)
  • Transfection
  • Tumor Suppressor Proteins (metabolism)
  • Ubiquitin-Protein Ligases
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: